anti-cancer vaccines
Scope
Date
~
-
Bio & Pharma
Gencurix supplies companion diagnostic kits to cancer center in India
South Korean biotech company Gencurix Inc. on Friday said it started supplying its companion diagnostic test Droplex to a national cancer center in ...
Aug 18, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Qurient, US National Cancer Institute to develop anti-cancer drug
South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...
Aug 14, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem to make first domestic 6-in-1 vaccine for infants
South Korea's LG Chem Ltd. will produce the nation's first homegrown six-in-one vaccine for infants, something that the country is entirely reliant ...
Aug 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Gencurix joins US gov't Cancer Moonshot project
South Korean cancer molecular diagnostics company Gencurix Inc. announced on Monday that it joins US President Joe Biden's cancer-conquering project...
Jul 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Boryung Pharma's sales surpass $311 mn in H1 2023
South Korea’s Boryung Corp. has alleviated the fear of falling behind in its sector expressed by its third-generation chairman Jay Kim Jung-Gy...
Jul 28, 2023 (Gmt+09:00)
-
Artificial intelligence
Lunit to supply AI diagnosis solution to Saudi's medical institution
South Korea's medical AI company Lunit announced on Wednesday that it has signed a contract to supply its artificial intelligence (AI) solution for ...
Jul 26, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's NGeneBio establishes US corporation NGeneBioAI
South Korean medical diagnostic company NGeneBio Co. announced on Monday that it has established an artificial intelligence (AI) precision diagnosti...
Jul 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Clinomics releases equipment that quickly finds lung cancer mutations
Clinomics, a South Korean biotech company specializing in liquid biopsies, on Thursday said it developed equipment that can detect four types of l...
Jul 21, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins approval for quadrivalent flu vaccine in Egypt
South Korea's GC Biopharma Corp. announced on Wednesday that its quadrivalent influenza vaccine "GC Flu Quadrivalent" has received approval from Egy...
Jul 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Novomics expands presence in Chinese cancer market
South Korean molecular diagnostics company Novomics Co. announced on Wednesday that it has signed a collaboration agreement with Chinese molecular d...
Jul 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma participates in US gov’t Cancer Moonshot
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, announced on Tuesday that it will partici...
Jul 18, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hyundai Wia completes flying drone interception test
Hyundai Wia Corp., an auto parts and defense unit of Hyundai Motor Group, announced on Thursday that the first shooting trial of its anti-drone syst...
Jul 06, 2023 (Gmt+09:00)
-
Bio & Pharma
SCM Lifescience kicks off anti-hair loss product exports to SE Asia
South Korea’s stem cell tech company SCM Lifescience on Wednesday said it has started full-scale exports to Southeast Asia of its hair loss ca...
Jul 06, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience, Thai’s GPO to jointly boost vaccine infrastructure
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Wednesday that it has signed a memorandum of understanding (MO...
Jul 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Jun 30, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio receives FDA approval for phase 1,2 trials of LCB84
South Korean pharmaceutical firm LegoChem Biosciences Inc. announced on Thursday that it has received approval from the US Food and Drug Administrat...
Jun 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Daehwa Pharm applies for approval of anti-dementia patch in China
South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...
Jun 16, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's SK Bioscience to resume domestic flu vaccine output
South Korea's SK Bioscience Co. will resume making domestic flu vaccines by year's end, two years after it stopped production to supply a vaccine fo...
Jun 14, 2023 (Gmt+09:00)
-
Bio & Pharma
CrystalGenomics to supply anti-osteoarthritis drug to Russia for $2 mn
South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...
Jun 08, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience’s COVID-19 vaccine gets approval in UK
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Monday that its domestic COVID-19 vaccine, SKYCovione, has rec...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine
South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...
May 23, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB submits new drug application to FDA for Rivoceranib liver cancer drug
HLB Co. announced on May 17 that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for the approval of Rivo...
May 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Lemonex signs MOU with WHO mRNA vaccines tech hub
South Korea's gene therapeutics developer Lemonex announced on Tuesday that it has signed a memorandum of understanding (MOU) with the World Health ...
May 09, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to produce MSD’s new Ebola vaccine candidate
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a contract with MSD, a global pharma...
May 08, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Aerospace invests in Israeli startup with anti-jamming tech
South Korea's Hanwha Aerospace Co. has invested in an Israeli start-up possessing anti-jamming technology to prevent interference in global position...
Apr 25, 2023 (Gmt+09:00)
-
Business & Politics
S.Korea wary of tougher US anti-China moves for chipmakers
South Korean President Yoon Suk Yeol on Monday kicked off a six-day state visit to the US with a tough assignment: finding diplomatic solutions for ...
Apr 24, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Ransomware attacks targeting S.Korean companies on sharp rise
Global hacker groups' ransomware attacks against domestic companies and organizations in the first quarter of this year have been revealed to total ...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-bio's NK cell therapy wins therapeutic approval for liver cancer
South Korean anti-cancer immunotherapy company Vaxcell-Bio Therapeutics announced on Friday that its natural killer (NK) cell therapy, Vax-NK/HCC, h...
Apr 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Verismo's CAR-T therapy designated fast-track status by FDA
Verismo Therapeutics, a US affiliate of South Korean pharmaceutical firm HLB Co., has received fast-track designation from the US Food and Drug Admi...
Apr 07, 2023 (Gmt+09:00)
-
Energy
Korea’s small nuclear reactor technology falls behind global peers
South Korea’s small-sized nuclear reactor technology has fallen behind other major countries due to the years of the previous government&rsquo...
Mar 31, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand